| Not Yet Recruiting | A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years Epstein-Barr Virus (EBV), Healthy Volunteers | — | 2026-04-20 |
| Completed | Phase 3 Single Arm, Open Study on vYF in Adults Yellow Fever | Phase 3 | 2025-10-23 |
| Recruiting | Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne Acne | Phase 1 / Phase 2 | 2025-07-03 |
| Active Not Recruiting | Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine Pneumococcal Infections | Phase 3 | 2025-02-28 |
| Completed | Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea Hepatitis B, Haemophilus Influenzae Type b Immunisation | — | 2025-01-17 |
| Active Not Recruiting | Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Ra Respiratory Syncytial Virus Immunization | — | 2025-01-13 |
| Active Not Recruiting | A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years o Influenza, Healthy Volunteers | Phase 1 / Phase 2 | 2025-01-06 |
| Active Not Recruiting | Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately Pneumococcal Immunization | Phase 3 | 2024-12-18 |
| Active Not Recruiting | Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years Influenza Immunization | Phase 1 / Phase 2 | 2024-12-09 |
| Terminated | A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus V RSV Immunisation | Phase 3 | 2024-11-25 |
| Active Not Recruiting | Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Na Human Metapneumovirus Immunization, Respiratory Syncytial Virus Immunization | Phase 1 / Phase 2 | 2024-11-11 |
| Active Not Recruiting | Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Meningococcal Immunization, Healthy Volunteers | Phase 1 / Phase 2 | 2024-11-05 |
| Completed | Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Influenza | Phase 3 | 2024-11-04 |
| Completed | Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participant Influenza Immunization | — | 2024-10-22 |
| Completed | Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Resp RSV Infection, hMPV | Phase 1 | 2024-10-09 |
| Completed | Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of Age Periodontal Disease | N/A | 2024-10-09 |
| Active Not Recruiting | Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in A Respiratory Syncytial Virus Infection, Metapneumovirus Infection, Parainfluenzae Virus Infection | Phase 1 | 2024-09-17 |
| Completed | Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years o Influenza, Healthy Volunteers | Phase 1 | 2024-08-12 |
| Terminated | Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants a RSV Immunization | Phase 3 | 2024-05-13 |
| Recruiting | Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe A Acne | Phase 1 / Phase 2 | 2024-04-05 |
| Completed | Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older Respiratory Syncytial Virus Infection, Healthy Volunteers | Phase 2 | 2024-04-02 |
| Completed | BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study) Respiratory Syncytial Virus | — | 2024-04-01 |
| Completed | A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Age Influenza Immunization | Phase 1 / Phase 2 | 2024-04-01 |
| Completed | Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers Meningococcal Immunisation, Healthy Volunteers | Phase 3 | 2024-03-19 |
| Terminated | Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers RSV Immunisation | Phase 3 | 2024-02-06 |
| Completed | Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory S Respiratory Syncytial Virus Infection, Healthy Volunteers, Metapneumovirus Infection | Phase 1 | 2024-01-23 |
| Completed | Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Meningococcal Infection, Healthy Volunteers | Phase 3 | 2024-01-18 |
| Completed | Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus | Phase 1 / Phase 2 | 2023-11-01 |
| Completed | Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents Meningococcal Immunisation, Healthy Volunteers | Phase 1 / Phase 2 | 2023-10-31 |
| Completed | Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless Meningococcal Immunisation, Healthy Volunteers | Phase 4 | 2023-09-07 |
| Completed | Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers Respiratory Syncytial Virus Infections | — | 2023-07-11 |
| Completed | Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutin Influenza Immunization | Phase 1 | 2023-04-12 |
| Completed | Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatr Meningococcal Immunisation, Healthy Volunteers | Phase 3 | 2023-03-27 |
| Completed | Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Respiratory Syncytial Virus Infection | Phase 1 / Phase 2 | 2023-02-06 |
| Recruiting | Dengvaxia US Pregnancy Registry Dengue Virus Infection | — | 2023-01-01 |
| Completed | Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age Influenza Immunization | Phase 1 / Phase 2 | 2022-12-12 |
| Completed | Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age Influenza Immunization | Phase 1 / Phase 2 | 2022-11-28 |
| Completed | Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adu Respiratory Syncytial Virus Immunization | Phase 1 / Phase 2 | 2022-11-17 |
| Terminated | Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Va Influenza Immunization | Phase 3 | 2022-11-10 |
| Completed | Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuva Influenza, Healthy Volunteers | Phase 1 / Phase 2 | 2022-11-03 |
| Completed | Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age. Influenza Immunization | Phase 3 | 2022-10-27 |
| Completed | Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2 Influenza (Healthy Volunteers) | — | 2022-10-06 |
| Completed | Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age Influenza Immunization | Phase 1 / Phase 2 | 2022-10-03 |
| Active Not Recruiting | Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administe Meningococcal Immunisation, Healthy Volunteers | Phase 3 | 2022-08-23 |
| Completed | Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Sy RSV Immunization, Healthy Volunteer | Phase 3 | 2022-08-08 |
| Completed | Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Influenza Immunization, Healthy Volunteers | Phase 1 | 2022-06-09 |
| Completed | Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants Influenza, Influenza Immunization | Phase 1 | 2022-04-11 |
| Completed | Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and T Dengue Virus Infection | — | 2022-03-11 |
| Completed | Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a L Influenza (Healthy Volunteers) | Phase 3 | 2021-12-07 |
| Completed | Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2 Influenza (Healthy Volunteers) | — | 2021-10-12 |
| Active Not Recruiting | Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia Yellow Fever | Phase 2 | 2021-10-07 |
| Completed | Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris Acne Vulgaris, Acne | Phase 1 | 2021-09-28 |
| Completed | Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations Influenza Immunization, Healthy Volunteers | Phase 4 | 2021-09-08 |
| Completed | Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomi Influenza Immunization, Healthy Volunteers | Phase 2 | 2021-07-16 |
| Active Not Recruiting | Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA Yellow Fever, Healthy Volunteers | Phase 2 | 2021-07-01 |
| Completed | Effectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the U Pertussis (Whooping Cough) | — | 2021-06-02 |
| Terminated | Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines Meningococcal Immunisation, Healthy Volunteers | Phase 1 | 2021-03-29 |
| Completed | Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococca Meningococcal Immunisation, Healthy Volunteers | Phase 3 | 2021-03-16 |
| Terminated | Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older COVID-19 | Phase 1 / Phase 2 | 2021-03-12 |
| Recruiting | Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to Men Meningococcal Infection | — | 2021-03-05 |
| Completed | Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 COVID-19 | Phase 2 / Phase 3 | 2021-02-24 |
| Completed | Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphth Pertussis Immunisation, Diphtheria Immunisation, Tetanus Immunisation | Phase 4 | 2021-01-27 |
| Completed | Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV- Influenza (Healthy Volunteers) | Phase 3 | 2020-11-10 |
| Completed | Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV- Influenza Immunization, Healthy Volunteers | Phase 3 | 2020-10-21 |
| Completed | Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposu Rabies (Healthy Volunteers) | Phase 3 | 2020-10-11 |
| Completed | Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers Respiratory Syncytial Virus Infection | Phase 1 / Phase 2 | 2020-09-17 |
| Completed | Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations Influenza Immunization, Healthy Volunteers | Phase 4 | 2020-09-16 |
| Terminated | Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine Influenza | Phase 3 | 2020-09-15 |
| Completed | Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older COVID-19 (Healthy Volunteers) | Phase 1 / Phase 2 | 2020-09-03 |
| Completed | Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and O COVID-19 | Phase 3 | 2020-08-20 |
| Completed | Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposu Rabies (Healthy Volunteers) | Phase 3 | 2020-08-04 |
| Completed | Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Ad Influenza Immunisation, Healthy Volunteers | Phase 1 | 2020-07-02 |
| Completed | Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Heal Pertussis Immunisation, Diphtheria Immunisation, Polio Immunisation | Phase 3 | 2020-06-28 |
| Completed | Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in H Pneumococcal Immunisation, Diphtheria Immunisation, Tetanus Immunisation | Phase 2 | 2020-05-22 |
| Terminated | Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV Genital Herpes | Phase 1 | 2020-02-18 |
| Active Not Recruiting | Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermi Dengue Fever | — | 2020-01-31 |
| Completed | Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in Adults Yellow Fever (Healthy Volunteers) | Phase 1 | 2020-01-15 |
| Completed | Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influen Influenza | Phase 3 | 2020-01-09 |
| Completed | Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Dengue Virus Infection | — | 2020-01-07 |
| Completed | Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults Meningococcal Immunization, Healthy Volunteers | Phase 3 | 2019-12-30 |
| Completed | Safety and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Formulations Containing Different H3 H Influenza | Phase 1 | 2019-11-06 |
| Completed | Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults Dengue Fever, Dengue Hemorrhagic Fever, Human Immunodeficiency Virus | Phase 2 | 2019-11-06 |
| Terminated | Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Stand Influenza (Healthy Volunteers) | Phase 3 | 2019-11-04 |
| Completed | Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV- Influenza Immunization, Healthy Volunteers | Phase 3 | 2019-10-28 |
| Completed | Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Reg Rabies, Healthy Volunteers | Phase 3 | 2019-10-21 |
| Completed | Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conju Meningococcal Infection (Healthy Volunteers) | Phase 3 | 2019-10-04 |
| Completed | Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Qu Influenza | Phase 4 | 2019-09-30 |
| Completed | Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococ Meningococcal Immunisation (Healthy Volunteers) | Phase 3 | 2019-09-12 |
| Completed | Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Meningococcal Immunisation (Healthy Volunteers) | Phase 3 | 2019-09-03 |
| Completed | Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Rabies (Healthy Volunteers) | Phase 3 | 2019-07-01 |
| Completed | A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Inves Tetanus Immunisation (Healthy Volunteers), Diphtheria Immunisation (Healthy Volunteers), Pertussis Immunisation (Healthy Volunteers) | Phase 1 | 2019-06-26 |
| Completed | Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vacci Healthy Volunteers (Meningococcal Infection) | Phase 3 | 2019-04-09 |
| Completed | Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine Influenza, Flu | Phase 1 | 2019-02-22 |
| Completed | Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam Influenza | Phase 3 | 2019-01-15 |
| Completed | Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Ro Meningococcal Infections | Phase 3 | 2018-12-14 |
| Completed | Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years) Pneumococcal Immunization | Phase 1 | 2018-12-03 |
| Completed | Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly Wi Healthy Volunteers (Meningococcal Infection) | Phase 3 | 2018-10-17 |
| Completed | Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Admin Healthy Volunteers (Meningococcal Infection) | Phase 3 | 2018-10-10 |
| Completed | Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Month Influenza | Phase 2 | 2018-10-09 |
| Completed | Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly W Healthy Volunteers (Meningococcal Infection) | Phase 3 | 2018-10-04 |
| Completed | Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscul Healthy Volunteers (Rabies Immunization) | Phase 3 | 2018-09-26 |
| Completed | Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Thei Influenza | — | 2018-09-17 |
| Completed | Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vac Healthy Volunteers (Meningococcal Infection) | Phase 3 | 2018-09-17 |
| Completed | Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza V Influenza | Phase 4 | 2018-09-10 |
| Completed | Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly Wi Healthy Volunteers (Meningococcal Infection) | Phase 3 | 2018-04-25 |
| Completed | Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea Yellow Fever | — | 2018-04-11 |
| Completed | Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children Meningococcal Infections | Phase 3 | 2018-02-27 |
| Completed | Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine Influenza | Phase 3 | 2017-12-19 |
| Completed | Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years Influenza | Phase 1 / Phase 2 | 2017-09-15 |
| Completed | Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines Influenza, Flu | Phase 4 | 2017-09-11 |
| Completed | Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US Influenza | Phase 3 | 2017-09-08 |
| Completed | Zika Case Definition and Surveillance Study Zika Virus Disease | — | 2017-04-29 |
| Completed | Immunogenicity and Safety of a Purified Vero Rabies Vaccine Rabies Virus | Phase 2 | 2017-04-17 |
| Completed | Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 3 | 2017-02-24 |
| Completed | Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 3 | 2017-02-17 |
| Terminated | Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subje Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | 2016-12-19 |
| Completed | Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine Dengue Fever, Dengue Hemorrhagic Fever | — | 2016-12-14 |
| Completed | Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gard Dengue Fever, Dengue Hemorrhagic Fever, Human Papillomavirus Disease | Phase 3 | 2016-12-01 |
| Completed | Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cerv Dengue Fever, Dengue Hemorrhagic Fever, Human Papillomavirus Disease | Phase 3 | 2016-11-16 |
| Completed | Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Todd Meningitis, Meningococcal | Phase 3 | 2016-11-07 |
| Completed | Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children Influenza | Phase 4 | 2016-09-23 |
| Completed | Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formu Influenza | Phase 4 | 2016-09-15 |
| Completed | Postmarketing Surveillance Study for IMOJEV® in Republic of Korea Japanese Encephalitis | — | 2016-07-21 |
| Completed | Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 4 | 2016-07-21 |
| Completed | Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Year Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 3 | 2016-07-15 |
| Completed | Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 3 | 2016-07-15 |
| Completed | DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infect Diphtheria, Tetanus, Pertussis | Phase 3 | 2016-07-14 |
| Completed | Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Complet Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | 2016-07-01 |
| Completed | Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Hea Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 2 | 2016-06-06 |
| Completed | Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | 2016-05-02 |
| Completed | Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 3 | 2016-04-15 |
| Completed | Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedu Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | 2016-04-14 |
| Completed | Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent D Dengue Fever, Dengue Haemorrhagic Fever | — | 2016-03-29 |
| Completed | Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federa Meningitis, Meningococcal Meningitis, Meningococcal Infections | — | 2016-02-01 |
| Completed | Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Va Hepatitis B | Phase 3 | 2016-02-01 |
| Completed | Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Year Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 4 | 2015-12-01 |
| Completed | Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Hepatitis B | N/A | 2015-11-01 |
| Completed | Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjec Tetanus, Diphtheria, Pertussis | Phase 1 / Phase 2 | 2015-10-22 |
| Completed | Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 4 | 2015-10-20 |
| Completed | Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Pregnancy, Influenza | — | 2015-10-13 |
| Completed | Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Given by Intramuscular Route in Subjects Aged 18 Influenza | Phase 3 | 2015-09-01 |
| Completed | Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines Influenza | Phase 4 | 2015-09-01 |
| Completed | A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years Influenza | Phase 2 | 2015-09-01 |
| Completed | Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Heal Influenza | Phase 4 | 2015-08-01 |
| Completed | Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in Influenza | Phase 3 | 2015-07-27 |
| Completed | Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route) Influenza | Phase 4 | 2015-06-17 |
| Completed | Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healt Japanese Encephalitis | Phase 3 | 2015-06-01 |
| Completed | Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Diphtheria, Tetanus, Pertussis | Phase 3 | 2015-04-20 |
| Completed | A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republ Cholera | Phase 3 | 2015-04-01 |
| Completed | Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddle Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 2 | 2015-03-31 |
| Completed | DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Ja Tetanus, Diphtheria, Pertussis | Phase 3 | 2014-10-01 |
| Completed | Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults Influenza | Phase 4 | 2014-10-01 |
| Completed | Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China Influenza | Phase 4 | 2014-09-01 |
| Completed | Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine Influenza | Phase 4 | 2014-08-01 |
| Completed | Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adoles Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 2 | 2014-07-22 |
| Completed | A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines Cholera | Phase 4 | 2014-03-01 |
| Completed | Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Tetanus, Diphtheria, Pertussis | Phase 3 | 2014-03-01 |
| Completed | DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Diphtheria, Tetanus, Pertussis | Phase 3 | 2014-03-01 |
| Completed | Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccin Diphtheria, Tetanus, Whooping Cough | Phase 3 | 2014-02-01 |
| Completed | Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Virus Diseases, Hepatitis B | Phase 3 | 2014-01-01 |
| Completed | Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adole Hepatitis A, Hepatitis A Virus | Phase 4 | 2013-12-01 |
| Completed | Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan Poliomyelitis, Polio | Phase 4 | 2013-12-01 |
| Completed | Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Dengue, Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | 2013-11-05 |
| Completed | Post-licensure Safety Study of IMOJEV® in Thailand Japanese Encephalitis | Phase 4 | 2013-11-01 |
| Completed | Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vac Diphtheria, Tetanus, Pertussis | Phase 3 | 2013-11-01 |
| Completed | Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents Influenza | Phase 3 | 2013-10-01 |
| Completed | Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Diphtheria, Tetanus, Whooping Cough | Phase 3 | 2013-10-01 |
| Completed | Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Effi Dengue, Dengue Fever, Dengue Hemorrhagic Fever | — | 2013-09-10 |
| Completed | Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis R Rabies | Phase 2 | 2013-09-01 |
| Completed | Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adult Influenza | Phase 4 | 2013-09-01 |
| Completed | Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine Influenza | Phase 4 | 2013-09-01 |
| Completed | Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry Pregnancy, Influenza | — | 2013-08-16 |
| Completed | Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China Diphtheria, Tetanus, Pertussis | Phase 1 | 2013-08-01 |
| Terminated | Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection Clostridium Difficile Infection | Phase 3 | 2013-07-30 |
| Completed | Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea Japanese Encephalitis | Phase 3 | 2013-07-11 |
| Completed | Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Jap Clostridium Difficile Infection | Phase 1 / Phase 2 | 2013-07-01 |
| Completed | Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Fed Meningitis, Meningococcal Infection | Phase 3 | 2013-06-25 |
| Completed | Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposur Rabies | Phase 2 | 2013-06-01 |
| Completed | Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U) Hepatitis A | — | 2013-04-01 |
| Completed | Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in H Neisseria Meningitidis, Bacterial Infections, Virus Diseases | Phase 3 | 2013-04-01 |
| Completed | Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use Rabies | Phase 2 | 2013-02-01 |
| Completed | Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 2 | 2012-11-12 |
| Completed | Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years Influenza | Phase 3 | 2012-10-01 |
| Completed | Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults. Influenza | Phase 4 | 2012-09-01 |
| Completed | Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in A Pertussis, Tetanus, Diphtheria | Phase 1 / Phase 2 | 2012-09-01 |
| Completed | Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formula Influenza | Phase 4 | 2012-09-01 |
| Completed | Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age Meningitis, Meningococcal Infection, Diphtheria | Phase 4 | 2012-07-01 |
| Completed | Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Meningitis, Meningococcal Disease | Phase 3 | 2012-07-01 |
| Completed | Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen Rabies | Phase 3 | 2012-06-29 |
| Completed | Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents Tetanus, Diphtheria, Pertussis | Phase 4 | 2012-06-01 |
| Completed | Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects Salmonella Infections, Typhoid Fever, Bacterial Infections | Phase 3 | 2012-05-01 |
| Completed | Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children Diphtheria, Tetanus and Pertussis | — | 2012-03-01 |
| Completed | Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India Dengue, Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | 2012-03-01 |
| Completed | Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and Adults Influenza | Phase 3 | 2012-03-01 |
| Completed | Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE Diphtheria, Tetanus, Poliomyelitis | Phase 4 | 2012-02-01 |
| Completed | Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Meningitis, Meningococcal Meningitis, Meningococcal Infections | Phase 3 | 2012-01-01 |
| Completed | Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vacc Dengue, Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | 2011-12-06 |
| Completed | Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China Diphtheria, Tetanus, Pertussis | Phase 4 | 2011-12-01 |
| Completed | Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Polio, Poliomyelitis | Phase 4 | 2011-11-01 |
| Completed | Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose Tetanus, Diphtheria, Pertussis | Phase 4 | 2011-11-01 |
| Completed | Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers Dengue, Dengue Hemorrhagic Fever, Yellow Fever | Phase 3 | 2011-09-07 |
| Completed | Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children Dengue, Dengue Fever, Dengue Hemorrhagic Fever | — | 2011-09-01 |
| Completed | Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine Meningitis, Meningococcal Infection | Phase 2 | 2011-09-01 |
| Completed | Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants Pneumonia, Pneumococcal Infections, Streptococcus Pneumoniae Infections | Phase 1 | 2011-09-01 |
| Completed | Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults Influenza | Phase 4 | 2011-09-01 |
| Completed | A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults Influenza | Phase 4 | 2011-09-01 |
| Completed | Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Health Diphtheria, Tetanus, Whooping Cough | Phase 3 | 2011-09-01 |
| Completed | Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Childr Meningococcal Disease, Meningitis | Phase 4 | 2011-08-01 |
| Completed | Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers Dengue, Dengue Hemorrhagic Fever | Phase 3 | 2011-07-18 |
| Completed | Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Tod Japanese Encephalitis, Japanese Encephalitis Virus Disease | Phase 3 | 2011-07-01 |
| Completed | Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan Poliomyelitis, Polio | Phase 3 | 2011-07-01 |
| Completed | Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin Am Dengue Fever, Dengue Hemorrhagic Fever, Dengue | Phase 3 | 2011-06-08 |
| Completed | Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia Dengue, Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | 2011-06-03 |
| Completed | Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Childre Meningitis, Meningococcal Infection | — | 2011-06-01 |
| Completed | Regulatory Post-Marketing Surveillance Study for TETRAXIM™ Diphtheria, Tetanus, Pertussis | Phase 4 | 2011-06-01 |
| Completed | Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizat Meningitis, Meningococcal Infection | Phase 3 | 2011-05-01 |
| Completed | Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies V Rabies, Rabies Virus | Phase 3 | 2011-04-01 |
| Completed | Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age Tetanus, Diphtheria, Pertussis | Phase 3 | 2011-04-01 |
| Completed | Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEV Diphtheria, Tetanus, Poliomyelitis | Phase 3 | 2011-01-01 |
| Completed | Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines Meningitis, Meningococcal Disease | Phase 4 | 2010-12-01 |
| Completed | A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China Polio, Poliomyelitis | Phase 4 | 2010-12-01 |
| Completed | A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age Influenza | Phase 2 | 2010-11-01 |
| Completed | Study of Quadrivalent Influenza Vaccine Among Children Influenza | Phase 3 | 2010-11-01 |
| Completed | Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | 2010-10-05 |
| Completed | Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules i Clostridium Difficile Infection, Diarrhea | Phase 2 | 2010-10-01 |
| Completed | Study of Quadrivalent Influenza Vaccine Among Adults Influenza | Phase 3 | 2010-10-01 |
| Completed | Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Diphtheria, Tetanus, Pertussis | Phase 3 | 2010-10-01 |
| Completed | Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea Influenza | Phase 4 | 2010-10-01 |
| Completed | Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV Japanese Encephalitis, Varicella | Phase 3 | 2010-08-25 |
| Completed | Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese To Japanese Encephalitis, Measles, Mumps | Phase 3 | 2010-08-01 |
| Completed | A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants Diphtheria, Tetanus, Whooping Cough | Phase 3 | 2010-08-01 |
| Completed | Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America Dengue, Dengue Hemorrhagic Fever | Phase 2 | 2010-08-01 |
| Completed | Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Ro Influenza | Phase 3 | 2010-06-01 |
| Completed | Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults Pneumococcal Infections, Streptococcus Pneumoniae Infections, Pneumococcal Pneumonia | Phase 1 | 2010-06-01 |
| Completed | Post Marketing Surveillance for ADACEL™ in South Korea Diphtheria, Tetanus, Pertussis | Phase 4 | 2010-06-01 |
| Completed | Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Influenza | Phase 3 | 2010-05-01 |
| Completed | A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults Influenza, Swine-origin A/H1N1 Influenza | Phase 2 | 2010-03-01 |
| Completed | A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddler Encephalitis, Japanese Encephalitis | Phase 3 | 2010-03-01 |
| Completed | Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines Pertussis | — | 2010-02-08 |
| Completed | Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India Influenza, Pandemic Influenza, Influenza A Virus, H1N1 Subtype | Phase 3 | 2010-01-01 |
| Completed | A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers Meningitis, Meningococcal Infection | Phase 2 | 2009-12-16 |
| Completed | Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults Influenza, Swine-Origin A/H1N1 Influenza Virus | — | 2009-12-01 |
| Completed | A Study to Assess the Safety of Adacel® Vaccine Diphtheria, Tetanus, Pertussis | Phase 3 | 2009-12-01 |
| Completed | A Study of Influenza Virus Vaccines in Children and Adults Influenza | Phase 2 | 2009-10-01 |
| Completed | Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin Dengue, Dengue Hemorrhagic Fever, Dengue Virus | Phase 2 | 2009-10-01 |
| Completed | A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months Influenza, Swine-origin A/H1N1 Influenza | Phase 2 | 2009-09-01 |
| Completed | Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM Influenza | Phase 2 | 2009-09-01 |
| Completed | Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Encephalitis, Japanese Encephalitis | Phase 3 | 2009-08-07 |
| Completed | A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years Influenza, Swine-origin A/H1N1 Influenza | Phase 2 | 2009-08-01 |
| Completed | A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly Influenza, Swine-origin A/H1N1 Influenza | Phase 2 | 2009-08-01 |
| Completed | A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly Influenza, Swine-origin A/H1N1 Influenza | Phase 2 | 2009-08-01 |
| Completed | A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years Influenza, Swine-origin A/H1N1 Influenza | Phase 2 | 2009-08-01 |
| Completed | Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy Adults Healthy | Phase 3 | 2009-07-01 |
| Completed | Study of Purified Vero Rabies Vaccine Serum Free Compared With Reference Purified Vero Rabies Vaccine in Healt Rabies | Phase 2 | 2009-07-01 |
| Completed | Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation Influenza | Phase 2 | 2009-05-01 |
| Completed | Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intrader Influenza | Phase 2 | 2009-05-01 |
| Completed | Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore Dengue Fever, Dengue Hemorrhagic Fever, Dengue Virus | Phase 2 | 2009-04-07 |
| Completed | Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly Poliomyelitis | Phase 2 | 2009-04-01 |
| Completed | Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in C Influenza, Orthomyxoviridae Infections, Orthomyxovirus Infections | Phase 2 | 2009-04-01 |
| Completed | Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | 2009-03-01 |
| Completed | Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease Haemophilus Infections, Diphtheria, Tetanus | — | 2009-02-01 |
| Completed | Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection Diarrhea, Clostridium Difficile Infection | Phase 2 | 2009-02-01 |
| Completed | Efficacy and Safety of Dengue Vaccine in Healthy Children Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | 2009-02-01 |
| Completed | Safety of a Second Dose of Biken's Varicella Vaccine Varicella | Phase 4 | 2009-01-01 |
| Completed | Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® V Meningococcal Infections, Meningitis | — | 2008-12-01 |
| Completed | Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults Orthomyxoviridae Infection, Influenza, Myxovirus Infection | Phase 3 | 2008-10-01 |
| Completed | A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccinati Hepatitis B | Phase 3 | 2008-10-01 |
| Completed | Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults West Nile Fever | Phase 2 | 2008-10-01 |
| Completed | Influenza Vaccine Revaccination in Ambulatory Elderly Subjects Influenza, Orthomyxovirus Infection, Myxovirus Infection | Phase 2 | 2008-10-01 |
| Completed | Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | 2008-09-26 |
| Completed | Database Surveillance Safety Study of PENTACEL® Vaccine Diphtheria, Tetanus, Pertussis | — | 2008-09-01 |
| Completed | Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzo Influenza, Orthomyxoviridae Infections | Phase 4 | 2008-09-01 |
| Completed | Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | 2008-08-01 |
| Completed | Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines Japanese Encephalitis, Hepatitis A | Phase 3 | 2008-08-01 |
| Completed | A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination Influenza | Phase 4 | 2008-08-01 |
| Completed | Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Fo Influenza, Orthomyxoviridae Infections | Phase 2 | 2008-06-01 |
| Completed | Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose Pertussis, Tetanus, Diphtheria | Phase 4 | 2008-06-01 |
| Completed | Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study Meningitis, Meningococcemia | Phase 2 | 2008-06-01 |
| Completed | Dose Comparison Study of Menactra® in US Children Meningitis, Meningococcal Infection, Neisseria Meningitidis | Phase 2 | 2008-06-01 |
| Terminated | Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma Melanoma, Cancer | Phase 2 | 2008-06-01 |
| Completed | Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants Diphtheria, Tetanus, Pertussis | Phase 3 | 2008-05-01 |
| Completed | Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers Meningitis, Meningococcal Infection | Phase 1 | 2008-04-01 |
| Completed | Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children Japanese Encephalitis, Hepatitis A | Phase 2 | 2008-03-01 |
| Completed | Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infan Diphtheria, Tetanus, Pertussis | Phase 3 | 2008-03-01 |
| Completed | Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly Poliomyelitis | Phase 2 | 2008-01-01 |
| Completed | Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healt Influenza | Phase 2 | 2008-01-01 |
| Completed | Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Diphtheria, Polio, Pertussis | Phase 3 | 2007-12-01 |
| Completed | Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar Streptococcus Pneumoniae | Phase 3 | 2007-11-01 |
| Completed | Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects Influenza, Orthomyxoviridae Infections | Phase 2 | 2007-11-01 |
| Completed | Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in A Influenza, Orthomyxoviridae Infections | Phase 2 | 2007-10-01 |
| Completed | Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine Influenza | Phase 3 | 2007-10-01 |
| Completed | Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® V Influenza | Phase 4 | 2007-10-01 |
| Completed | Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ Meningococcal Infections, Meningococcal Meningitis | Phase 1 / Phase 2 | 2007-10-01 |
| Completed | Immunology and Safety of Menactra® in Children in Saudi Arabia Meningitis, Meningococcemia | Phase 3 | 2007-09-01 |
| Completed | Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix Diphtheria, Tetanus, Pertussis | Phase 3 | 2007-09-01 |
| Completed | Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines Influenza, Orthomyxovirus Infections, Myxovirus Infection | Phase 2 | 2007-09-01 |
| Completed | Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Diphtheria, Tetanus, Pertussis | Phase 3 | 2007-09-01 |
| Completed | Trial to Describe the Safety and Immunogenicity of Fluzone® Influenza | Phase 2 | 2007-08-01 |
| Completed | A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine Influenza, Orthomyxoviridae Infections | Phase 2 | 2007-06-01 |
| Completed | Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose Hepatitis A | Phase 3 | 2007-06-01 |
| Completed | Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children Influenza, Orthomyxoviridae Infections, Influenza A Virus Infection | Phase 2 | 2007-06-01 |
| Completed | Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers Meningococcal Meningitis, Measles, Mumps | Phase 3 | 2007-05-01 |
| Completed | Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age Tetanus, Diphtheria, Pertussis | Phase 3 | 2007-04-01 |
| Completed | Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia Neisseria Meningitidis, Meningococcal Infections | Phase 3 | 2007-02-01 |
| Completed | REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children Diphtheria, Tetanus, Poliomyelitis | Phase 3 | 2007-02-01 |
| Completed | Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Pandemic Influenza, Influenza A Virus Infection, Orthomyxoviridae Infections | Phase 1 | 2007-01-01 |
| Completed | Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers Meningococcal Meningitis, Measles, Mumps | Phase 3 | 2006-12-01 |
| Completed | Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants Diphtheria, Tetanus, Pertussis | Phase 3 | 2006-11-01 |
| Withdrawn | Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD) Smallpox, Atopic Dermatitis | Phase 1 | 2006-10-01 |
| Completed | Trial to Collect Safety Data and Sera for Immunogenicity Testing Influenza | Phase 4 | 2006-10-01 |
| Completed | Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Hepatitis B, Polio, Diphtheria | Phase 3 | 2006-10-01 |
| Completed | Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Orthomyxoviridae Infection, Influenza, Myxovirus Infection | Phase 3 | 2006-10-01 |
| Completed | Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formul Influenza | Phase 4 | 2006-10-01 |
| Completed | Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vac Influenza | Phase 4 | 2006-10-01 |
| Terminated | Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive HIV Infections, Smallpox | Phase 1 | 2006-10-01 |
| Completed | A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers Meningococcal Meningitis, Measles, Mumps | Phase 3 | 2006-09-01 |
| Completed | Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults Orthomyxoviridae Infection, Influenza, Myxovirus Infection | Phase 3 | 2006-09-01 |
| Completed | Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Va Measles, Mumps, Rubella | Phase 4 | 2006-09-01 |
| Completed | Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Preve Infant, Healthy | Phase 3 | 2006-09-01 |
| Completed | Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elde Orthomyxoviridae Infection, Influenza, Myxovirus Infection | Phase 3 | 2006-09-01 |
| Completed | Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paedia Hepatitis B, Polio, Diphtheria | Phase 3 | 2006-08-01 |
| Completed | Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Diphtheria, Tetanus, Pertussis | Phase 3 | 2006-08-01 |
| Completed | Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine Tetanus, Diphtheria, Pertussis | Phase 4 | 2006-08-01 |
| Completed | Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Pr Diphtheria, Pertussis, Polio | Phase 2 | 2006-08-01 |
| Completed | A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Compara Meningococcal Immunization | Phase 1 | 2006-07-25 |
| Completed | Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and Diphtheria, Tetanus, Pertussis | Phase 3 | 2006-07-01 |
| Completed | Burden of Respiratory Syncytial Virus (RSV) in Children in Sweden (BRICS): A Retrospective Study in Sweden Respiratory Syncytial Virus (RSV) | — | 2006-07-01 |
| Completed | A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine Influenza, Orthomyxoviridae Infections | Phase 2 | 2006-07-01 |
| Completed | Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and To Diphtheria, Tetanus, Pertussis | Phase 3 | 2006-07-01 |
| Completed | Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Hepatitis B, Polio, Diphtheria | Phase 3 | 2006-07-01 |
| Completed | Safety of REPEVAX® Given One Month After REVAXIS® Healthy Adult | Phase 3 | 2006-06-01 |
| Completed | Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy I Diphtheria, Tetanus, Pertussis | Phase 3 | 2006-06-01 |
| Completed | Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV Poliomyelitis, Polio | Phase 3 | 2006-06-01 |
| Completed | Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly Influenza, Orthomyxoviridae Infections | Phase 2 | 2006-06-01 |
| Completed | Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine Pertussis, Diphtheria, Tetanus | Phase 4 | 2006-03-01 |
| Completed | Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule Pertussis, Diphtheria, Tetanus | Phase 3 | 2006-02-01 |
| Completed | Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in th Orthomyxoviridae Infection, Influenza, Myxovirus Infection | Phase 2 | 2006-01-01 |
| Completed | Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine Pertussis | — | 2006-01-01 |
| Completed | Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Meno Meningitis, Meningococcal Infection | Phase 2 | 2006-01-01 |
| Completed | Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults West Nile Fever | Phase 2 | 2005-12-01 |
| Completed | Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menom Meningitis, Meningococcal Infection | Phase 2 | 2005-12-01 |
| Completed | Safety of Imovax Polio in Chinese Infants and Children Poliomyelitis | Phase 3 | 2005-11-01 |
| Completed | Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan Diphtheria, Tetanus, Pertussis | Phase 3 | 2005-11-01 |
| Completed | Safety and Immune Response of Different Pediatric Combination Vaccines. Diphtheria, Polio, Pertussis | Phase 3 | 2005-11-01 |
| Completed | Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine Influenza | Phase 4 | 2005-10-01 |
| Completed | Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Mont Influenza | Phase 3 | 2005-10-01 |
| Completed | Immunogenicity Study of the Influenza Vaccine in Adults Orthomyxoviridae Infections, Influenza | Phase 2 | 2005-09-01 |
| Completed | Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine Influenza | Phase 4 | 2005-09-01 |
| Completed | Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine Smallpox | Phase 2 | 2005-07-01 |
| Completed | Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine Meningitis, Meningococcal Disease | — | 2005-07-01 |
| Completed | 36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds Meningitis, Meningococcal Disease | — | 2005-07-01 |
| Completed | Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine Meningitis, Meningococcemia, Pertussis | Phase 4 | 2005-04-01 |
| Completed | Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age Influenza | Phase 1 / Phase 2 | 2005-04-01 |
| Completed | Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or Diphtheria, Tetanus, Pertussis | Phase 3 | 2005-03-01 |
| Completed | Immunogenicity and Safety of Verorab™ in Indian Population Rabies | Phase 4 | 2004-12-01 |
| Completed | Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age Meningitis, Meningococcal Infection | Phase 2 | 2004-12-01 |
| Completed | Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinea Diphtheria, Tetanus, Pertussis | Phase 2 | 2004-10-01 |
| Completed | Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age Pertussis, Diphtheria | — | 2004-09-01 |
| Completed | Study of Safety and Immunogenicity of Fluzone® in Healthy Children Influenza | Phase 4 | 2004-09-01 |
| Completed | Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® Vaccine Influenza | Phase 4 | 2004-08-01 |
| Completed | Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td Diphtheria, Tetanus | Phase 4 | 2004-05-01 |
| Completed | Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adult Smallpox | Phase 1 | 2004-04-01 |
| Completed | Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents Meningitis, Meningococcemia | Phase 2 | 2004-02-01 |
| Completed | Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ Diphtheria, Tetanus, Pertussis | Phase 4 | 2004-02-01 |
| Terminated | Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy A Meningitis, Meningococcemia | Phase 2 | 2004-01-01 |
| Completed | Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone® Influenza | Phase 4 | 2003-09-01 |
| Completed | Retrospective Survey of Safety of Fourth Dose Pentacel® in Children Diphtheria, Pertussis, Haemophilus Infection | — | 2003-09-01 |
| Completed | Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adu Influenza, Orthomyxoviridae Infection, Myxovirus Infection | Phase 2 | 2003-09-01 |
| Completed | Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children Meningitis, Meningococcemia | Phase 2 | 2003-08-01 |
| Completed | A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination Influenza | Phase 4 | 2003-07-01 |
| Completed | Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjuga Meningitis, Meningococcemia, Neisseria Meningitidis | Phase 2 | 2003-03-01 |
| Completed | Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune® Meningococcal Infections, Meningitis | Phase 4 | 2002-10-01 |
| Terminated | Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Va Smallpox | Phase 2 | 2002-09-01 |
| Completed | Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Pol Pertussis, Tetanus, Diphtheria | Phase 2 | 1999-01-01 |